- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
TEVA
Value Investors Should Buy into the Teva Stock Dip
Teva stock is now at yearly lows, a victim of negative macro news, falling stock markets, and year-end tax-loss selling.
Should Warren Buffett — And You — Buy More TEVA Stock Right Now?
Teva's turnaround is working, but a serious worry is now hitting shares. Should you be buying more TEVA stock with this looming danger?
6 Pharmaceutical Stocks to Buy After the Midterms
The upside case for pharmaceutical stocks is building. The midterm elections results mean its unlikely drug price regulation will happen soon.
Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow
Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.
Teva Wins Approval From FDA for Blockbuster Migraine Drug
The markets are ignoring the potential sales growth for Teva's migraine drug. Value investors should look at Teva stock now.
5 Top Stock Trades for Tuesday — Trading Oracle, FedEx Earnings
FedEx and Oracle are set to report earnings, while JD and Teva were in the news as we manage our top stock trades heading into Tuesday. Here's what you need to know.
Why Teva’s Outlook Is Mixed
TEVA stock is on a comeback rally after suffering two years of horrific losses, but its outlook is mixed.
EpiPen Shortage 2018: 13 Things for Parents to Know
An EpiPen shortage has parents worried as the school season starts back up across the U.S., but there are other options.
5 Top Stock Trades for Friday Morning — Trading Nvidia Earnings
Here are the trading levels to keep in mind for Nvidia. Walmart, J.C. Penney and JD.com all post huge moves after reporting their quarterly results. Here are our top stock trades for Friday.
Why Teva Pharmaceutical Stock Is Sinking Today
Teva Pharmaceutical (TEVA) stock was down on Thursday following the release of its earnings report for the second quarter of 2018.
Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play
Teva Pharmaceuticals is quietly moving higher on the stock market for good reason: worries over pricing and the impact of competition in generics is getting clearer. Teva stock is a great long-term bet.
5 Top Stock Trades for Tuesday Morning
Friday was a quiet session in the stock market, particularly with the holiday on Monday coming up. Here are our top stock trades to make when the markets resume trading after Memorial Day.
Warren Buffett Loves TEVA Stock and You Should Too
Teva Pharmaceuticals has been on the run, and a nod of confidence from Warren Buffett certainly helps matters. Teva stock can continue to rally if momentum stays with it.
FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.